Bruna Pellini, MD
@BrunaPellini
Assistant Member & Thoracic Oncologist @moffittnews Co-Chair @NIH Liquid Biopsy SIG @SWOG #Lung TM Subcommittee Tweets are mine #lungcancer #ctdna #KRAS
ID:1285211737336291329
https://moffitt.org/providers/bruna-pellini/ 20-07-2020 13:55:40
946 Tweets
1,6K Followers
779 Following
Follow People
Dive deep into the world of lung cancer biomarker testing with Bruna Pellini, MD (@MoffittNews) and Semir Vranić (@QatarUniversity) - Precision Oncology CONNECT
oncodaily.com/55877.html
#oncodaily #oncology #cancer #lungcancer #biomarkertesting #oncology #podcast
⭐️Thank you Dr. Singhi Eric K. Singhi, MD for joining us MedNewsWeek on OncLive.com and sharing your compelling journey to become a Thoracic Oncologist MD Anderson Cancer Center . H. Jack West, MD Stephen V Liu, MD Aakash Desai, MD, MPH Yan Leyfman, MD Jacob J. Adashek, DO
👇Full video click👇
onclive.com/mednews-week/m…
Dive deep into the world of lung cancer biomarker testing with Bruna Pellini, MD and Semir Vranić in Part 2 of our podcast series!
Join the Association for Molecular Pathology-endorsed discussion moderated by Oncology Brothers, and to receive insights on the pre-analytical phase
Listen now: ow.ly/ps3B50Rm4xc
Very excited to have Dennis Lo deliver the opening address at the NIH #LiquidBiopsy conference that I’m co-chairing with All-⭐️s Adam Sowalsky Bruna Pellini, MD Aaron Newman Lab.
Should be one heck of a conference! See you there/then National Cancer Institute in Bethesda!!
GFH375 (VS-7375): An oral, selective #KRAS G12D (ON/OFF) inhibitor with potent anti-tumor efficacy.
#AACR24 Anirban Maitra LARVOL Daniel Gerlach Darryl B McConnell Vivek Subbiah, MD David S. Hong MD soria Jay Bradner, M.D. Stephen V Liu, MD Bruna Pellini, MD Filip Janku Scott Kopetz Ziyang Zhang Simanshu Dhirendra
Right in time for #AACR24 !!
Checkout Bruna Pellini, MD’s and my commentary on lung cancer disparities Cancer Epidemiology, Biomarkers & Prevention
“Racial disparities in early-stage NSCLC treatment: A Call for Action”
aacrjournals.org/cebp/article/d…
#Disparities in treatment of early-stage #lungcancer Bruna Pellini, MD Aadel Chaudhuri, MD PhD
Grateful for the insightful session on lung cancer and career growth by OncLive.com at #AACR2024 . Engaging discussions with speakers on crucial topics. Bruna Pellini, MD Robert Hsu MD and Dr. Wakabayashi. Big thanks to OncLive.com and Regeneron for organising this insightful session!
Aadel Chaudhuri, MD PhD , gave a great presentation in a Multi-omics session. Thank you for sharing how lymphatic fluid is an emerging tool in optimizing patient outcomes!
Stop by our poster session tomorrow to learn more:
abstractsonline.com/pp8/#!/20272/p…
Thank you OncLive.com for the invitation to review data on #perioperativeIO for #NSCLC and to share my experience in #careerdevelopment in #oncology Having the opportunity to interact with trainees from different institutions and to hear the career stories of Robert Hsu MD and Mark
Great kick-off meeting for International Society of Liquid Biopsy membership committee today! Dr. Luis E. Raez Bruna Pellini, MD
Level up your #Oncology career! Attend our lung cancer seminar for Fellows on April 6th in San Diego. Learn effective self-marketing & networking skills to advance your career. Bruna Pellini, MD Robert Hsu MD #NSCLC #LungCancer #Oncology Fellows
REGISTER: ow.ly/oexk50QUKeb
Our lung cancer seminar for #OncologyFellows is happening on April 6th in San Diego! Gain valuable insights from Bruna Pellini, MD of @moffittnews. Network & build your career! Bruna Pellini, MD Robert Hsu MD #NSCLC #LungCancer
REGISTER: ow.ly/54vA50QUJWs
Narjust Florez, MD, FASCO Clinical Care Options Ticiana Batista (Leal) Ana I. Velázquez Mañana, MD MSc (she/her/ella) Maria Antonia Vélez Charu Aggarwal, MD, MPH, FASCO What are the advantages and limitations of liquid biopsy?
Liquid biopsy 💉🩸 has the potential for longitudinal monitoring of response to therapy.
There is a scope now to understand the biology of therapy resistant SCLC with this platform!
Christian Rolfo Bruna Pellini, MD
Triparna Sen (Sen-Lab) Narjust Florez, MD, FASCO Clinical Care Options Ticiana Batista (Leal) Ana I. Velázquez Mañana, MD MSc (she/her/ella) Maria Antonia Vélez Charu Aggarwal, MD, MPH, FASCO Christian Rolfo Bruna Pellini, MD Misty Dawn Shields Dr. Nagla Abdel Karim Luis Paz-Ares LiveLung Lung Cancer Research Foundation Clarissa Mathias May I cite myself?
lungcancerjournal.info/article/S0169-…
It is expressed almost universally. And disease is quite heterogeneous. On top of that we have all the RNA signature data. My take is that DLL3 expression is not going to be an USEFUL biomarker.
Oncology Fellows: Deepen your knowledge of the latest #LungCancer treatments at our seminar on April 6th in San Diego! Bruna Pellini, MD Robert Hsu MD #NSCLC #OncologyFellows
REGISTER: ow.ly/l0sG50QUJS2
Here's our latest from Johns Hopkins Thoracic Oncology & Molecular OncologyLab, hot-off-the-press in Nature Medicine. What do we learn from neoadjuvant anti-PD1 & anti-LAG3 through the lens of liquid biopsies? Enjoy the read!
nature.com/articles/s4159…
Vincent Lam Cancer Research Institute Blair Landon